GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced the launch of GoodRx Employer Direct. The new offering enables employers to directly lower the cost of ...
GoodRx (NASDAQ:GDRX) executives said the company ended 2025 with what it called “disciplined execution” across strategic ...
GoodRx Holdings, Inc. recently reported fourth-quarter 2025 revenue of US$194.79 million and full-year revenue of US$796.85 million, alongside the launch of GoodRx Employer Direct to help employers ...
JP Morgan analyst Lisa C. Gill revised her 2025 outlook on GoodRx Holdings (NASDAQ:GDRX) following the company’s first-quarter earnings. Gill reaffirmed an Overweight rating on the stock and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results